FECAL MATTER FOR PREVENTING OR TREATING INTESTINAL MICROBIOME ABERRATIONS IN CESAREAN SECTION-BORN INFANTS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 16, 2023
app pub date -
Sep 24, 2021
filing date -
Sep 24, 2021
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
A composition for use in the prevention or treatment of intestinal microbiota aberration in a Cesarean section- (CS-) born infant, wherein the use is particularly for one or more of reducing intestinal colonization of pathogenic microorganisms, increasing intestinal relative abundance of Bacteroides species and/or Bifidobacterium species, increasing intestinal microbial diversity, increasing level of intestinal secretory IgA and/or intestinal antimicrobial peptides, reducing susceptibility to a disorder particularly chosen from the group consisting of metabolic disease, obesity, type 2 diabetes, auto-immune disease, atopy-related disease, allergy and asthma, and increasing immune response to vaccines.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully